Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Delayed Adjuvant Herceptin® Treatment in Patients With HER-2 Positive Breast Cancer

This study has been terminated.
(lack of accrual)
Sponsor:
Information provided by:
University of California, Los Angeles
ClinicalTrials.gov Identifier:
NCT00427427
First received: January 25, 2007
Last updated: October 25, 2007
Last verified: October 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2007
  Estimated Primary Completion Date: No date given